Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer
2010 ◽
Vol 107
(12)
◽
pp. 1923-1929
◽
2018 ◽
Vol 25
(5)
◽
pp. 573-584
Keyword(s):
2009 ◽
Vol 2
(1)
◽
pp. 44-52
◽
2014 ◽
Vol 24
(5)
◽
pp. 1235-1243
◽
Keyword(s):
2007 ◽
Vol 177
(4S)
◽
pp. 7-7
◽
Keyword(s):
2004 ◽
Vol 171
(4S)
◽
pp. 42-42
◽
2003 ◽
Vol 57
(2)
◽
pp. S437